Access cutting-edge rectal cancer treatment through this clinical trial at a research site in New Brunswick. Study-provided care at no cost to qualified participants.
Access rectal cancer specialists in New Brunswick at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rectal cancer treatment provided free
To evaluate the safety and preliminary efficacy of Preoperative ChemoRadiation and FOLFOXIRI and to Escalate Complete Response for Rectal Cancer patients.Go through laboratory and medical tests to verify eligibility to enter the study, receive the experimental combination of drugs (chemoradiation (capecitabine and radiation) + FOLFOXIRI (Oxaliplatin, leucovorin, irinotecan, and fluorouracil) prior to surgery and undergo laboratory tests and study procedures on specified days during the study per
Sponsor: Rutgers, The State University of New Jersey
Check if you qualify for this rectal cancer clinical trial in New Brunswick, NJ
If you're searching for rectal cancer treatment options in New Brunswick, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Brunswick research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.